Construction and immunogenicity of an mRNA vaccine against chikungunya virus

Construction and immunogenicity of an mRNA vaccine against chikungunya virus

Chikungunya fever (CHIKF) has spread to more than 100 countries worldwide, with frequent outbreaks in Europe and the Americas in recent years. Despite the relatively low lethality of infection, patients can suffer from long-term sequelae. Until now, no available vaccines have been approved for use;...

Full description

Bibliographic Details
Main Authors: Jingjing Liu, Xishan Lu, Xingxing Li, Weijin Huang, Enyue Fang, Wenjuan Li, Xiaohui Liu, Minglei Liu, Jia Li, Ming Li, Zelun Zhang, Haifeng Song, Bo Ying, Yuhua Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
chikungunya virus
mRNA vaccine
immunogenicity
sequential immunization
prime-boost
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129118/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129118/full

Similar Items